The Effects of Two Nrf2 Activators, Bardoxolone Methyl and Omaveloxolone, on Retinal Ganglion Cell Survival during Ischemic Optic Neuropathy
Nonarteritic anterior ischemic optic neuropathy (NAION) is one of the most common acute optic neuropathies that affect the over 55-year-old population. NAION causes the loss of visual function, and it has no safe and effective therapy. Bardoxolone methyl (methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien...
Main Authors: | Jia-Ying Chien, Yu-Yau Chou, Jhih-Wei Ciou, Fang-Yun Liu, Shun-Ping Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/9/1466 |
Similar Items
-
Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates
by: Reisman SA, et al.
Published: (2019-04-01) -
Synthetic oleanane triterpenoids suppress MYB oncogene activity and sensitize T-cell acute lymphoblastic leukemia cells to chemotherapy
by: Paloma Tejera Nevado, et al.
Published: (2023-04-01) -
Protective effects of compound M01 on retinal ganglion cells in experimental anterior ischemic optic neuropathy by inhibiting TXNIP/NLRP3 inflammasome pathway
by: Jia-Ying Chien, et al.
Published: (2023-12-01) -
Omaveloxolone inhibits IL-1β-induced chondrocyte apoptosis through the Nrf2/ARE and NF-κB signalling pathways in vitro and attenuates osteoarthritis in vivo
by: Zengxin Jiang, et al.
Published: (2022-09-01) -
The Protective Effects of n-Butylidenephthalide on Retinal Ganglion Cells during Ischemic Injury
by: Yu-Yau Chou, et al.
Published: (2022-02-01)